Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study

T. Sarycheva, N. Capkova, A. Pająk, S. Malyutina, G. Simonova, A. Tamosiunas, M. Bobák, H. Pikhart

. 2022 ; 23 (1) : 140. [pub] 20220531

Language English Country Great Britain

Document type Journal Article, Multicenter Study

BACKGROUND: The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries. METHODS: This prospective population-based cohort includes men and women aged 45-69 years, residents in urban settlements in Czech Republic, Poland, Russia and Lithuania, randomly selected from population registers. The baseline survey in 2002-2005 included 36,106 persons of whom 24,993 met the inclusion criteria. Cox proportional hazards models were used to estimate the hazard ratios of mortality over 11-16 years of follow-up for mild, moderate, moderate-severe and very severe lung function impairment categories. RESULTS: After adjusting for covariates, mild (hazard ratio (HR): 1.25; 95% CI 1.15‒1.37) to severe (HR: 3.35; 95% CI 2.62‒4.27) reduction in FEV1 was associated with an increased risk of death according to degree of lung impairment, compared to people with normal lung function. The association was only slightly attenuated but remained significant after exclusion of smokers and participants with previous history of respiratory diseases. The HRs varied between countries but not statistically significant; the highest excess risk among persons with more severe impairment was seen in Poland (HR: 4.28, 95% CI 2.14‒8.56) and Lithuania (HR: 4.07, 95% CI 2.21‒7.50). CONCLUSIONS: Reduced FEV1 is an independent predictor of all-cause mortality, with risk increasing with the degree of lung function impairment and some country-specific variation between the cohorts.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018289
003      
CZ-PrNML
005      
20220804134658.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12931-022-02057-y $2 doi
035    __
$a (PubMed)35641974
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sarycheva, Tatyana $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Koltarska 2, 611 37, Brno, Czech Republic. tatyana.sarycheva@recetox.muni.cz
245    10
$a Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study / $c T. Sarycheva, N. Capkova, A. Pająk, S. Malyutina, G. Simonova, A. Tamosiunas, M. Bobák, H. Pikhart
520    9_
$a BACKGROUND: The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries. METHODS: This prospective population-based cohort includes men and women aged 45-69 years, residents in urban settlements in Czech Republic, Poland, Russia and Lithuania, randomly selected from population registers. The baseline survey in 2002-2005 included 36,106 persons of whom 24,993 met the inclusion criteria. Cox proportional hazards models were used to estimate the hazard ratios of mortality over 11-16 years of follow-up for mild, moderate, moderate-severe and very severe lung function impairment categories. RESULTS: After adjusting for covariates, mild (hazard ratio (HR): 1.25; 95% CI 1.15‒1.37) to severe (HR: 3.35; 95% CI 2.62‒4.27) reduction in FEV1 was associated with an increased risk of death according to degree of lung impairment, compared to people with normal lung function. The association was only slightly attenuated but remained significant after exclusion of smokers and participants with previous history of respiratory diseases. The HRs varied between countries but not statistically significant; the highest excess risk among persons with more severe impairment was seen in Poland (HR: 4.28, 95% CI 2.14‒8.56) and Lithuania (HR: 4.07, 95% CI 2.21‒7.50). CONCLUSIONS: Reduced FEV1 is an independent predictor of all-cause mortality, with risk increasing with the degree of lung function impairment and some country-specific variation between the cohorts.
650    12
$a kardiovaskulární nemoci $x epidemiologie $7 D002318
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a plíce $7 D008168
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Polsko $x epidemiologie $7 D011044
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Capkova, Nadezda $u National Institute of Public Health, Prague, Czech Republic
700    1_
$a Pająk, Andrzej $u Department of Epidemiology and Population Sciences, Institute of Public Health, Jagiellonian University Medical College, Kraków, Poland
700    1_
$a Malyutina, Sofia $u Research Institute of Internal and Preventive Medicine - Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia $u Novosibirsk State Medical University, Novosibirsk, Russia
700    1_
$a Simonova, Galina $u Research Institute of Internal and Preventive Medicine - Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia
700    1_
$a Tamosiunas, Abdonas $u Laboratory of Population Research, Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania
700    1_
$a Bobák, Martin $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Koltarska 2, 611 37, Brno, Czech Republic $u Research Department of Epidemiology and Public Health, University College London, London, UK
700    1_
$a Pikhart, Hynek $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Koltarska 2, 611 37, Brno, Czech Republic $u Research Department of Epidemiology and Public Health, University College London, London, UK
773    0_
$w MED00006600 $t Respiratory research $x 1465-993X $g Roč. 23, č. 1 (2022), s. 140
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35641974 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134652 $b ABA008
999    __
$a ok $b bmc $g 1822067 $s 1169532
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 23 $c 1 $d 140 $e 20220531 $i 1465-993X $m Respiratory research $n Respir Res $x MED00006600
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...